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Extended manned space flight will result in a diminution of immune status and cause profound changes in the 
human bacterial microbiota, leading to increased risk of infection. Experiments conducted during short-term 
flight suggest that growth in microgravity leads to increases in bacterial antibiotic resistance and to cell wall 
changes. Growth under low-shear modelled microgravity (LSMMG) indicated that a reduced gravitational field 
acts as an environmental signal for expression of enhanced bacterial virulence in Gram-negative pathogens. We 
examined the effect of simulated microgravity on parameters of virulence in clinical isolates of Staphylococcus 
aureus. Three strains were grown under LSMMG in a High Aspect Ratio Vessel and compared with cells grown 
under normal gravity (NG) in the same vessel. There were no significant differences in the antibiotic 
susceptibility, growth rate or morphology of staphylococci grown under LSMMG compared to NG. LSMMG-
induced reductions in synthesis of the pigment staphyloxanthin were noted. Strains secreted less protein under 
LSMMG and reductions in haemolysin secretion were found. Reduced expression of the major virulence 
determinant "-toxin in the microgravity environment was found by gene amplification. Thus, in contrast to 
published data on Gram-negative pathogens, simulated microgravity reduces the expression of key virulence 





Plans to resume manned missions to the Moon and 
to launch manned flights from the lunar surface for 
the purpose of Martian exploration will provide 
enormous challenges to those responsible for the 
provision of biomedical support. In addition to the 
well-documented extended flight risks associated 
with microgravity-induced decreases in bone 
mineral density, psychological problems due to 
isolation, noise, confinement and a restricted 
working environment, muscular atrophy, decreased 
cardiovascular performance, and prolonged 
exposure to ionising and non-ionising forms of 
radiation [1], microbial infections will almost 
certainly arise due to decreases in immune function. 
Analysis of medical events among astronauts 
aboard the Russian space station Mir from March 
1995 to June 1998 indicated that a significant 
number of episodes of infection occurred, including 
conjunctivitis and acute respiratory and dental 
infections [2]. In addition, injury and trauma, such 
as lacerations and open fractures, are likely to occur 
on long missions and will require prophylactic 
administration of antibiotics to prevent serious 
wound infection. 
On-board infections will most likely originate from 
the endogenous human flora of the crew, although 
microbial contamination of the fabric of the 
spacecraft and its air and water supply has been 
noted [3]. Even brief space flight induces changes 
in the composition of the intestinal [4], oral [5,6] 
and nasal [6] bacterial microflora and crew 
members are susceptible to in-flight cross-
contamination with opportunistic pathogens such as 
Staphylococcus aureus via the upper respiratory 
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tract [6]. The negative impact of space travel on the 
function of cells of the immune system [7,8] are 
exacerbated by reductions in the diversity of the 
normal bacterial flora and a relative increase in the 
numbers of opportunistic pathogens at sites such as 
the nasal passage [9]. 
Treatment of on-board infections could be 
compromised by reversible increases in antibiotic 
resistance. Experiments aboard Soviet [10,11] and 
American [12,13] vessels have indicated that the 
antibiotic susceptibility of both Gram-positive and 
Gram-negative bacteria may be significantly 
reduced during flight. For example, the minimum 
inhibitory concentration (MIC) of colistin and 
kanamycin required to kill Escherichia coli 
increased fourfold in comparison to ground 
experiments when determined aboard Salyut 7; the 
reduction in oxacillin, erythromycin and 
chloramphenicol susceptibility of a S. aureus isolate 
was accompanied by large increases in the 
thickness of the cell wall, an effect often intimately 
associated with changes in sensitivity to antibiotics. 
These on-board experiments strongly suggest that 
growth of these medically important bacteria in a 
microgravity environment changes the bacterial 
phenotype in a way that may render them antibiotic 
resistant. Also of concern for the well being of 
flight crew is the gathering evidence that 
microgravity may act as an environmental signal for 
expression of enhanced bacterial virulence [14]. 
Nickerson and coworkers [15] determined that 
Salmonella enterica serovar Typhimurium grown 
under low-shear modelled microgravity (LSMMG) 
using a high aspect ratio vessel (HARV) displayed 
enhanced virulence for mice compared to bacteria 
grown under normal gravity: LSMMG-grown cells 
had a decreased LD50, produced shortened time to 
death of infected test animals, and more readily 
colonized the liver and spleen. The processes 
involved in LSMMG-induced gene regulation 
appear to be novel and may be microgravity-
specific [16]. We believe that there is an urgent 
need for these pioneering studies to be extended to 
include other groups of pathogens, particularly 
opportunistic Gram-positive bacteria frequently 
associated with the human microflora and likely to 
pose a risk of infection on extended missions. We 
have therefore investigated the effect of simulated 
microgravity on the parameters of antibiotic 
susceptibility and virulence in clinical isolates of 
the Gram-positive pathogen S. aureus. 
MATERIALS AND METHODS 
 
Bacterial strains and reagents. The methicillin 
susceptible S. aureus (MSSA) isolates RF1, RF6 
and RF11 were from clinical samples processed at 
the Royal Free Hospital, London and were a gift 
from J.M.T. Hamilton-Miller. The following 
companies kindly provided the antibiotics used in 
this study: GlaxoSmithKline (flucloxacillin), Eli 
Lilly (vancomycin hydrochloride) and Sanofi 
Aventis (erythromycin). 
Bacterial culture. Bacterial cells were grown in 
Müller-Hinton (MH) broth (Oxoid, Basingstoke, 
UK) using Synthecon RCCS-1 HARVs (obtained 
from Cellon S.A., Bereldange, Luxembourg) 
housed in a 37oC incubator. Shake flask MH broth 
cultures were incubated for 16 h at 37oC, diluted 
1:50 in fresh MH broth and transferred into the 
bioreactor compartment. Care was taken to ensure 
that the reactor was completely filled with medium 
and that there was a complete absence of air 
bubbles. The bioreactors were then orientated to 
grow cells under conditions of LSMMG (rotation 
about the horizontal axis) or normal gravity (NG; 
rotation about the vertical axis). In all experiments, 
LSMMG and NG cultures were grown 
simultaneously with a rotation rate of 25 rpm for up 
to 24 h. To determine growth rates, samples were 
removed via the sampling port and the OD600 
measured. In all other experiments, cells were 
harvested after 24 h incubation. The culture 
supernatants were concentrated 30-fold using 
Vivaspin 20 ultrafiltration spin columns (Generon 
Ltd., Berkshire, UK). 
MIC. The MICs for flucloxacillin, vancomycin and 
erythromycin against the three MSSA isolates were 
determined by the broth dilution method using 
serial twofold dilutions of the antibiotics. Assays 
were performed in 96-well microtitre trays with an 
inoculum of 104 CFU in 100 :l of MH broth. S. 
aureus ATCC29213 was used as a reference strain 
to ensure comparability with published data. MIC 
values were obtained after incubation at 37ºC for 
24 h. The MIC was determined to be the lowest 
antibiotic concentration at which no visible 
bacterial growth occurred. 
Electron microscopy. For scanning electron 
microscopy (SEM), bacteria were recovered by 
centrifugation and washed twice with phosphate 
buffered saline (PBS). Cells were fixed in 1.5% w/v 
glutaraldehyde for at least 2 h at room temperature, 
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washed once with 70% ethanol and twice in 100% 
ethanol. Air-dried, gold-coated preparations were 
examined using a FEI XL30 scanning electron 
microscope. For transmission electron microscopy 
(TEM), the cells were recovered by centrifugation 
and washed twice in PBS. Bacteria were fixed in 
1.5% w/v glutaraldehyde for at least 2 h at room 
temperature, treated with osmium tetroxide and 
embedded in epoxy resin. Sectioning and staining 
with uranyl acetate was followed by Reynolds’ lead 
citrate. Ultra-thin sections were viewed and 
photographed using a Philips 201 transmission 
electron microscope. 
Assays for staphylococcal haemolytic activity. 
Defibrinated sheep or rabbit blood (10 ml; E&O 
Laboratories, Bonnybridge, UK) was centrifuged 
(1,000 g, 15 min), the erythrocytes washed three 
times with PBS and then suspended in cold sterile 
PBS to a concentration of 1% v/v. A normalized 
volume of culture supernatant was added to aliquots 
of this suspension to give a combined final volume 
of 1.5 ml and the mixtures incubated at 37ºC for 30 
min, followed by 25 min at 4ºC. After 
centrifugation to remove intact cells, the degree of 
erythrocyte lysis was determined 
spectrophotometrically (A540 nm). 
Extraction and quantification of carotenoids. 
Staphyloxanthin and intermediate carotenoids were 
extracted and quantified according to Wieland and 
coworkers [17]. Bacteria were harvested by 
centrifugation (3,000 g, 10 min) and washed twice 
with PBS. The packed cells were either extracted 
immediately or could be maintained at -20ºC for up 
to 3 months without their carotenoid content being 
affected. The cells (10 mg dry weight) were 
suspended in 500 :l of methanol, held at 55ºC in 
water bath for 5 minutes, cooled and extracts 
obtained by centrifugation. The extraction was 
repeated twice, until no further pigment could be 
extracted. Carotenoids were estimated 
quantitatively by measuring absorbance of solutions 
at 462nm, the absorbance maximum of the primary 
carotenoid pigment staphyloxanthin. 
Expression of virulence determinants. Proteins were 
separated by SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE); the concentration of 
acrylamide used was 10% w/v. Proteins were 
visualised by staining with Coomassie blue. 
RESULTS AND DISCUSSION 
 
There are a number of studies demonstrating that a 
range of bacteria grown under batch culture 
conditions during space flight yield higher final cell 
concentrations and total biomass, have increased 
growth rate and a shorter lag phase in comparison 
to terrestrial laboratory cultures [18-20]. These 
effects are attributed in the main to the influence of 
reduced gravity and this contention is supported by 
observations of bacterial growth under LSMMG. 
Thus, the Gram-negative bacteria Salmonella 
enterica [21] and E. coli [22] have been shown to 
display increased rates of division and reach a 
higher cell density under LSMMG, although these 
effects could not be demonstrated with 
Pseudomonas aeruginosa [23]. These studies were 
undertaken using minimal salts medium: when S. 
enterica was examined following growth in 
complex Luria-Bertani broth, the growth kinetics of 
LSMMG-grown cells were identical to those 
obtained under NG conditions [21]. As changes in 
growth kinetics induced by LSMMG may impact 
on other parameters of interest, we compared the 
growth rates of S. aureus grown under NG and 
LSMMG (Fig. 1). No differences in growth kinetics 
over the 24h culture period were seen with any of 
the three clinical isolates examined. As 
staphylococci have complex nutritional 
requirements, these experiments could not be 
undertaken using chemically defined minimal salts 
media. Thus, our data obtained with nutritionally 
complex MH broth lend some support to the view 
that the combination of minimal medium and 
LSMMG induce increased metabolic activity that 












Fig. 1: Growth kinetics of S. aureus RF1 under normal gravity 
(■) and simulated microgravity (□). Similar growth curves 







There were also no discernable differences in 
staphylococcal cell morphology as revealed by 
SEM (Fig. 2) or TEM (Fig. 3). This is in marked 
contrast to results obtained with a S. aureus strain 
isolated from the automicroflora of the astronaut J. 
L. Crétien; when cultured in nutritionally complex 
medium aboard Salyut 7 in July 1982, electron 
microscopy revealed large increases in the 
thickness of the cell wall in comparison to the earth 
control [10,12]. The reasons for this disparity are 
unclear but factors other than microgravity may 
have been brought to bear during the space flight 
experiments. 
 
Fig. 2: Scanning electron microscopy images of S. aureus RF6 
grown under normal gravity (A) and simulated 
microgravity (B). 
 
In marked contrast to in-flight investigations 
conducted in nutritionally complex medium with 
the Crétien S. aureus isolate [10,12], we found no 
changes in the susceptibility of RF1, RF6 and RF11 
to the acrolide antibiotic erythromycin, the β-
lactam flucloxacillin and the glycopeptide 
vancomycin (Table 1). These agents were selected 
for investigation because they interact with 
different targets in the bacterial cell: erythromycin 
interrupts the early stages of protein synthesis by 
binding to the 50S ribosomal subunit whereas 





er normal gravity (A) and 
simulated microgravity (B). 
different steps in cell wall peptidoglycan synthesis. 
. 3: Transmission electron microscopy images of sections of 






 Minimum inhibitory concentration (mg/L) 
 RF1  RF6  RF11 
Antimicrobial 
Agent  NG LSMMG  NG LSMMG  NG LSMMG 
Erythromycin  1 1  0.25 0.12  >128 >128 
Flucloxacillin  0.25 0.12  0.25 0.25  0.12 0.12 
Vancomycin  1 1  0.5 0.5  1 1 
 
Table 1: Influence of simulated microgravity on the susceptibility of S. aureus isolates RF1, RF6 and RF11 to 
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ontributes significantly to morbidity and mortality 
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ct on a number of factors associated with the 
less protein than NG-cultured bacteria an
quantity of some
virulence of S. aureus. The majority of S. aureus 
strains produce carotenoid pigments that impart the 
golden hue to colonies of this pathogen; the main 
pigment is staphyloxanthin, a triterpenoid esterified 
with a C15 fatty acid [25]. A recent study has linked 
carotenoid pigment synthesis to staphylococcal 
virulence; mutants unable to synthesise these 
molecules have impaired survival within neutrophils 
and are less pathogenic in a mouse subcutaneous 
abscess model [26]. All three strains that we 
examined produced less staphyloxanthin when 
grown under simulated microgravity compared to 
NG-grown cells (Fig. 4). 
(□). Error bars represent 1S
Fig. 4: Production of staphyloxanthin by S. aureus isolates 
grown under normal gravity (■) and simulated microgravity 
p<0.01. 
 
phylococcal pathogenesis is multifactorial and 
ti
addition, cell surface-bound proteins that recognize 
adhesive matrix molecules such as fibronectin- and 
collagen-binding protein, along with cell surface 
components such as the capsule and peptidoglycan, 
play a key role in determining the capacity of 
staphylococci to cause disease in humans. Secreted 
proteins enable the organism to attack the cellular 
and structural elements of diverse tissues and organs 
of the infected host and contribute to the spread of 
the pathogen and its ability to produce symptoms of 
disease. We have therefore focused our attention on 
some of these key secreted virulence determinants. 
The three isolates secrete a wide array of proteins 
into the surrounding medium and there are clear 
differences in protein secretion patterns between 
these strains (Fig. 5). Microgravity cultures secreted 
the growth medium was markedly reduced. The 
largest reduction in protein secretion occurred with 
RF6 (Fig. 5). Interestingly, the secretion of a few 
proteins was increased under LSMMG: for example, 
RF6 and RF11 appeared to increase the secretion of 
a protein with a molecular mass of ca 24kDa. We are 
in the process of identifying the nature of this 
protein. 
Fig. 5: SDS-PAGE of proteins secreted by S. aureus isolates 
visualised with Comassie blue. Cells were grown under 
normal gravity (NG) and simulated microgravity (LSSMG). 
Lanes:
 
st S. aureus isolates secrete one or more 
otoxic proteins that have the capacity to lyse red 
od cells. α-toxin, the hla gene product, is one of 
 most pote
c
in human infections [27]. A significant number of S. 
aureus strains produce additional haemolysins such 
as β-toxin, δ-toxin, γ-toxin and other less well-
characterised biocomponent toxins [27]. The three 
isolates that we have examined secreted toxins that 
lysed erythrocytes from sheep blood (Fig. 6a); all the 
major membrane-active staphylococcal exotoxins 
possess lytic activity against erythrocytes of this 
animal species [27,28]. Growth under LSMMG 
reduced the expression of sheep erythrocyte 
haemolysins in all isolates; with RF6 the effect was 
marked with toxin secretion almost completely 
absent. As the β-haemolysin, in contrast to the α- 
1 2 3 4 5 6 M 



















and δ- forms, is unable to lyse rabbit erythrocytes 
[28], we examined the capacity of culture 
supernatants to lyse red cells from this animal 
species (Fig. 6b). LSMMG-grown bacteria 
possessed less haemolytic activity and the largest 
difference was again found with strain RF6; 
comparison of Fig. 6a and 6b indicates that β-toxin 
activity made a significant contribution to the overall 
lytic profile of RF6 against sheep erythrocytes. 
 
Fig. 6: Secretion of sheep (A) and rabbit (B) erythrocyte 
haemolysins by S. aureus strains grown under normal 
gravity (■) and simulated microgravity (□). Error bars 
represent 1SD; n=5-6. *Paired Student’s t test, p<0.01. 
 
Few studies have been undertaken to determine the 
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tor that may impact on the well being of flight 
c
colleagues [15,24] have provided strong evidence 
that growth in LSMMG substantially increases the 
lethality of S. enterica for mice and increased their 
capacity to survive in stressed environments, 
including survival within macrophages. DNA 
microarray analysis determined that LSMMG 
differentially regulated the expression of a large 
number of genes of functional diversity; although 
the regulatory elements of the LSMMG-mediated 
phenotype have yet to be identified, there is 
evidence that the ferric uptake regulator fur is 
involved in the LSMMG response [16]. As the 
virulence of Gram-negative pathogens such as S. 
enterica is less reliant on the elaboration of 
extracellular proteins that damage the infected host 
than specialised Gram-positive pathogens such as 
members of the streptococci and staphylococci, we 
examined the effect of LSMMG on the expression of 
factors known to mediate the pathogenesis of S. 
aureus. As these organisms constitute a ubiquitous 
threat to human health in a variety of scenarios, 
modulation of virulence by mechanical stimuli such 
as microgravity should throw light on those factors 
that mediate their capacity to cause disease. 
Although we have not directly measured LSMMG-
induced changes in the infectivity of staphylococci, 
we have shown that, in sharp contrast to the data 
produced with Gram-negative bacteria, factors that 
correlate with virulence are down regulated to a 
greater or a lesser extent by LSMMG cultivation. 
Moreover, we found no evidence that microgravity 
decreased the susceptibility of S. aureus to 
antibiotics and it is difficult to reconcile this 
outcome with the experiments conducted aboard 
Salyut 7, Challenger and Discovery in the period 
1982-1992, save that influences other than gravity 
may play a role in determining outcome in the space 
environment [29]. We are currently attempting to 
determine the underlying regulatory processes that 
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